<DOC>
	<DOC>NCT00662883</DOC>
	<brief_summary>To assess the effects of nasal corticosteroid treatment on the rate and extent of intranasal absorption of PMI-150 (intranasal ketamine HCl)</brief_summary>
	<brief_title>Assessing the Effects of a Nasal Corticosteroid on PMI-150 (Intranasal Ketamine)</brief_title>
	<detailed_description>Subjects will participate in a two-period, single-sequence study to assess the effects of administration of a nasal corticosteroid, Nasonex (mometasone furoate), on the pharmacokinetics, safety and tolerability of PMI-150 (intranasal ketamine HCl) in healthy adult volunteers.</detailed_description>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<criteria>healthy adults nonsmoker no drug use nasal abnormalities airway abnormalities</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>ketamine</keyword>
	<keyword>corticosteroid</keyword>
	<keyword>intranasal</keyword>
	<keyword>phase I</keyword>
	<keyword>Healthy volunteers</keyword>
</DOC>